ENDPOINTS

Republican tax cut bill includes PBM, drug price negoti...

The latest version of a massive and wide-ranging tax cut bill includes several p...

Roche could rethink $50B US expansion plan if new polic...

Roche said its $50 billion promise to expand its manufacturing footprint in the ...

Exclusive: Patrick Hsu’s startup Stylus Medicine launch...

Stylus Medicine, an ambitious startup founded by Patrick Hsu, has raised $85 mil...

Trump signs ‘most favored nation’ order to try to lower...

The White House plans to force down prices of drugs sold in the US by threatenin...

#EASL25: Vir’s hep B disappointment, new data on Ipsen'...

The annual meeting of the European Association for the Study of the Liver (EASL)...

FDA clears in vivo blood stem cell editing trial; Abeon...

Plus, news about CytomX, Valneva, Lenz and Lotus Pharmaceutical:

White House threatens ‘most favored nation’ plan to low...

The White House outlined plans to force down prices of drugs sold in the US usin...

Lilly says further head-to-head trial data back Zepboun...

Eli Lilly said Sunday that new data on Zepbound show the GIP/GLP-1 dual agonist ...

How Toyota Owners Can Extend Vehicle Life with OEM Parts

BeeLines Automotive delivers high-quality used OEM parts—engines, transmissions ...

Trump confirms 'most favored nation' drug price plans

President Donald Trump said he'll take executive action to have the US pay no mo...

Where to Buy Quality Used Acura Engines in Florida

Find high-quality used Acura engines at CarEnginePart.com—affordable, tested, an...

Trump confirms 'most-favored nation' drug price plans

President Donald Trump said he'll take executive action to have the US pay no mo...

Makary names Vinay Prasad CBER chief; Q1 earnings repor...

Welcome back to Endpoints Weekly — thanks for starting your Saturday with us. It...

Chronic care startup Omada Health files to go public

Virtual diabetes and chronic care startup Omada Health filed to go public on Fri...

AstraZeneca reports Phase 3 win for Imfinzi; Roche to b...

Plus, news about Sanofi, Lilly, Minghui, Qilu, Sirius Therapeutics, Keros Therap...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.